AdaptHealth Corp. (NASDAQ:AHCO) Stake Boosted by American Century Companies Inc.

American Century Companies Inc. raised its stake in AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 30.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 210,359 shares of the company's stock after purchasing an additional 48,736 shares during the quarter. American Century Companies Inc. owned about 0.16% of AdaptHealth worth $2,003,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the stock. Teacher Retirement System of Texas grew its stake in AdaptHealth by 134.1% during the 4th quarter. Teacher Retirement System of Texas now owns 45,225 shares of the company's stock valued at $431,000 after purchasing an additional 25,909 shares in the last quarter. Intech Investment Management LLC grew its position in shares of AdaptHealth by 100.2% during the fourth quarter. Intech Investment Management LLC now owns 119,417 shares of the company's stock worth $1,137,000 after buying an additional 59,767 shares in the last quarter. Corient Private Wealth LLC raised its holdings in AdaptHealth by 37.9% in the fourth quarter. Corient Private Wealth LLC now owns 21,155 shares of the company's stock valued at $201,000 after acquiring an additional 5,811 shares in the last quarter. Royce & Associates LP boosted its stake in AdaptHealth by 29.0% during the 4th quarter. Royce & Associates LP now owns 1,002,755 shares of the company's stock valued at $9,546,000 after acquiring an additional 225,350 shares during the last quarter. Finally, Swiss National Bank grew its holdings in AdaptHealth by 1.7% during the 4th quarter. Swiss National Bank now owns 171,900 shares of the company's stock worth $1,636,000 after acquiring an additional 2,900 shares in the last quarter. 82.67% of the stock is currently owned by hedge funds and other institutional investors.

AdaptHealth Trading Down 3.3 %

AHCO traded down $0.30 during trading on Friday, reaching $8.66. The company had a trading volume of 1,608,048 shares, compared to its average volume of 1,215,108. The firm's 50-day simple moving average is $9.86 and its 200 day simple moving average is $10.07. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24. The company has a market cap of $1.17 billion, a price-to-earnings ratio of -5.25, a PEG ratio of 1.08 and a beta of 1.44. AdaptHealth Corp. has a 12-month low of $8.35 and a 12-month high of $11.90.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on AHCO. Canaccord Genuity Group upped their price target on AdaptHealth from $13.00 to $14.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. UBS Group cut their price target on AdaptHealth from $12.00 to $11.00 and set a "buy" rating on the stock in a report on Thursday, February 13th. Truist Financial boosted their price objective on AdaptHealth from $12.00 to $14.00 and gave the company a "buy" rating in a research report on Wednesday, February 26th. Royal Bank of Canada increased their target price on AdaptHealth from $11.00 to $14.00 and gave the stock an "outperform" rating in a research report on Wednesday, February 26th. Finally, Robert W. Baird lifted their price target on AdaptHealth from $14.00 to $16.00 and gave the company an "outperform" rating in a report on Thursday, February 27th. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus price target of $13.80.

AdaptHealth Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.